Inno Bio Diagnostics has agreed to invest about $1.3 million to establish a facility at Universiti Kebangsaan Malaysia Medical Centre that will develop stem cell treatments. Inno Bio and UKMMC will jointly operate the facility to create human hepatocyte-like cells derived from embryos, bone marrow and other sources of stem cells.

Related Summaries